Suppr超能文献

椎体转移瘤后凸成形术中的术中放疗(Kypho-IORT):初步临床结果

Intraoperative radiotherapy during kyphoplasty for vertebral metastases (Kypho-IORT): first clinical results.

作者信息

Reis Tina, Schneider Frank, Welzel Grit, Schmidt René, Bludau Frederic, Obertacke Udo, Wenz Frederik

机构信息

Department of Radiation Oncology, University Medical Centre Mannheim, University of Heidelberg, Germany.

出版信息

Tumori. 2012 Jul-Aug;98(4):434-40. doi: 10.1177/030089161209800406.

Abstract

AIMS AND BACKGROUND

Kyphoplasty is an effective procedure providing structural stability and pain alleviation in vertebral metastases. To prevent early regrowth, patients typically receive postoperative fractionated radiotherapy, which is associated with long treatment duration. Therefore, we established a new approach to deliver intraoperative radiotherapy during kyphoplasty to shorten the treatment time and reach structural stability and sterilization of the metastases (Kypho-IORT).

METHODS AND STUDY DESIGN

For Kypho-IORT, a 50 kV X-ray source with a specially designed applicator was used. A radiation dose of 8 Gy in 5 mm distance was delivered. After radiation the device was removed and the kyphoplasty was completed according to the standard procedure. Since August 2009, 18 patients with instable or painful spinal metastases received Kypho-IORT. The median age was 63 years (range, 43-73).

RESULTS

Kypho-IORT was successfully performed in 18 of 21 vertebral lesions (86%). No severe complications occurred during or early after IORT. The median pain score using a visual analogue scale decreased from 5/10 before the procedure to 2.5/10 at day 1 (P <0.001) and to 0/10 six weeks after the procedure (P = 0.001). Imaging studies were available for 15 of 18 patients. Stable disease within the irradiated vertebral body was seen in 14 patients (93%) and local progressive disease in one patient (7%). No re-irradiation due to local progressive disease or pain recurrence was necessary within the median follow-up of 4.5 months.

CONCLUSIONS

Kypho-IORT is well tolerated without severe side effects and provides fast improvement of pain. Although stable disease was seen in 93% of the patients, a longer follow-up is necessary to assess the effectiveness. A dose escalation study to establish the maximally tolerated dose has been initiated.

摘要

目的与背景

椎体成形术是一种在椎体转移瘤中提供结构稳定性和缓解疼痛的有效手术。为防止早期再生长,患者通常接受术后分次放疗,这与较长的治疗时间相关。因此,我们建立了一种在椎体成形术期间进行术中放疗的新方法,以缩短治疗时间并实现转移瘤的结构稳定和灭活(椎体成形术中放疗,Kypho-IORT)。

方法与研究设计

对于Kypho-IORT,使用了带有特殊设计施源器的50 kV X射线源。在5毫米距离处给予8 Gy的辐射剂量。辐射后移除设备,并按照标准程序完成椎体成形术。自2009年8月以来,18例不稳定或疼痛性脊柱转移瘤患者接受了Kypho-IORT。中位年龄为63岁(范围43 - 73岁)。

结果

21个椎体病变中的18个(86%)成功进行了Kypho-IORT。术中或术后早期未发生严重并发症。使用视觉模拟量表的中位疼痛评分从术前的5/10降至术后第1天的2.5/10(P <0.001),术后六周降至0/10(P = 0.001)。18例患者中有15例可进行影像学检查。14例患者(93%)在照射的椎体内出现疾病稳定,1例患者(7%)出现局部进展性疾病。在4.5个月的中位随访期内,无需因局部进展性疾病或疼痛复发而再次放疗。

结论

Kypho-IORT耐受性良好,无严重副作用,并能快速缓解疼痛。尽管93%的患者出现疾病稳定,但需要更长时间的随访来评估有效性。已启动剂量递增研究以确定最大耐受剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验